Wednesday, 20 August 2014

Commonly prescribed antibiotic 'could increase risk of cardiac death'

Clarithromycin belongs to a class of drugs known as macrolide antibiotics. It is used to treat an array of bacterial infections, including pneumonia, bronchitis and ear, sinus, skin and throat infections.
According to the research, macrolide antibiotics increase the duration of the heart muscle's electrical activity - known as the QT interval - which can lead to abnormal heart rhythm (arrhythmia), a known risk factor for stroke and sudden cardiac arrest.
Heart failure: transplantation of animal organs into human patients 'more viable'
Heart transplantation is the main treatment for end stage heart failure. Heart patients awaiting a transplant must rely on mechanical devices, which can increase the risk of infection, blood clots and bleeding in the patient.
A proposed alternative has been to use animal hearts in human patients, which is known as "xenotransplantation."
Scientists have reported success in transplanting the hearts from genetically engineered piglets into the abdomens of baboons, where the hearts have survived for more than 1 year. 

Firstly, pigs were genetically engineered to be a source of donor organs. These pigs had human genes that make their organs more compatible with human physiology. Pigs were chosen because their anatomy is similar to human anatomy.

Monday, 18 August 2014

Dear All,

Please find below the workshop brochure. If interested kindly mail us at smitha.p@acriindia.comPost your confirmation, mode of payment would be communicated to you.

For any queries kindly contact - 08049203 714, 715, 09538872289.





                                                          
ACRI-Clinical Research Institute
#33, 3rd Flr, 15th Cross, 100ft Outer Ring Road,
2nd Phase J.P. Nagar, Bangalore – 560078


Tuesday, 5 August 2014

WORKSHOP ON BASIC SAS

We are pleased to invite you to a one day workshop on one of the most significant topics – Basic SAS [Statistical Analytical Software] which would be conducted by ACRI in the first week of September, 2014.


SAS training would indeed provide a career with better growth potential and more options in terms of variety of jobs. There is a steady demand for SAS professionals throughout the pharmaceutical industry. It is crucial for Pharmaceutical companies, Biotechs and CRO’s to have SAS expertise from both statistical and data management point of view.

So come one, come all and get the best out of this valuable workshop. 

Kindly confirm your interest by calling 08049203714/715.